Olaplex (NASDAQ:OLPX – Get Free Report) issued its quarterly earnings data on Monday. The company reported $0.02 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.01, Briefing.com reports. Olaplex had a positive return on equity of 1.07% and a negative net margin of 2.19%.The firm had revenue of $99.37 million during the quarter, compared to analyst estimates of $94.11 million. The business’s revenue was up 2.5% on a year-over-year basis.
Olaplex Trading Down 0.2%
Shares of NASDAQ OLPX traded down $0.01 during midday trading on Monday, hitting $2.04. The company’s stock had a trading volume of 3,110,055 shares, compared to its average volume of 3,811,396. Olaplex has a 12-month low of $0.99 and a 12-month high of $2.04. The company has a current ratio of 4.58, a quick ratio of 4.00 and a debt-to-equity ratio of 0.40. The firm has a market cap of $1.37 billion, a P/E ratio of -203.50 and a beta of 1.87. The business’s 50 day moving average is $1.76 and its two-hundred day moving average is $1.49.
Insider Buying and Selling at Olaplex
In other Olaplex news, insider Trisha L. Fox sold 26,426 shares of the stock in a transaction on Monday, March 9th. The stock was sold at an average price of $1.26, for a total value of $33,296.76. Following the sale, the insider owned 721,169 shares in the company, valued at $908,672.94. This trade represents a 3.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, General Counsel John C. Duffy sold 34,962 shares of the company’s stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $1.26, for a total transaction of $44,052.12. Following the completion of the transaction, the general counsel owned 982,855 shares in the company, valued at approximately $1,238,397.30. The trade was a 3.43% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 215,442 shares of company stock valued at $271,457 in the last quarter. 4.20% of the stock is owned by insiders.
Institutional Inflows and Outflows
Analyst Ratings Changes
OLPX has been the topic of several recent research reports. Telsey Advisory Group upped their price objective on Olaplex from $2.00 to $2.06 and gave the stock a “market perform” rating in a report on Friday, March 27th. Canaccord Genuity Group downgraded shares of Olaplex from a “strong-buy” rating to a “hold” rating in a report on Thursday, March 26th. Evercore set a $2.50 target price on shares of Olaplex in a research report on Friday, March 6th. Wall Street Zen upgraded Olaplex from a “sell” rating to a “hold” rating in a research report on Saturday, March 7th. Finally, Jefferies Financial Group reissued a “buy” rating on shares of Olaplex in a research note on Wednesday, March 4th. One equities research analyst has rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Reduce” and an average target price of $1.92.
Get Our Latest Stock Analysis on OLPX
Olaplex Company Profile
Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.
Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.
Further Reading
- Five stocks we like better than Olaplex
- AI Dividend Increases: 3 Massive Winners Boosting Payouts
- Manic Monday.com: The Rally Is Just the Beginning for this SaaS Leader
- 5 Stocks Positioned to Benefit From the AI Inference Boom
- Meta Platforms’ Wild Post-Earnings Swings: Where Analyst Price Targets Stand Now
Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.
